Australia: Market and legal data analysis of the cannabis sector

Australian study finds objective scientific evidence that cannabis increases sleep

Written by Tiziana Cauli | 21st November 2024

Cannabis may help sleep, according to Australian researchers who found evidence of the hypnotic properties of cannabinol (CBN) and say their study is the first to use objective measures to prove CBN increases sleep ...

Brazil becomes top market for Colombia’s cannabis exports amid regulatory shifts

Written by CannIntelligence | 13th September 2024

In 2023, nearly a third – around $3.4m – of Colombia's total cannabis exports went to Brazil, driven by regulatory shifts and Colombia’s determination to dominate the international cannabis market ...

Australians use medical cannabis to treat pain, mental issues, survey results show

Written by Tiziana Cauli | 11th June 2024

Nearly eight years after the legalisation of medical cannabis in Australia, most people who use it to treat a health condition obtain it legally, through a doctor’s prescription ...

New Zealand reclassifies low-dose CBD medical products, effects yet to be seen

Written by Fernanda Tucunduva | 24th October 2023

Low-dose CBD products can now be supplied in New Zealand by registered pharmacists without a prescription after Medsafe reclassified CBD from a prescription-only medicine to a restricted (pharmacist-only) medicine ...

Australia’s Greens submit ‘solidly founded bill’ for cannabis legalisation

Written by Tiziana Cauli | 11th August 2023

The Australian Greens party has submitted the country’s first bill for the legalisation of recreational cannabis on a national level following a public consultation it held on its draft version ...

Cannabis companies shed US assets to focus on more lucrative markets

Written by Lorraine Mullaney | 27th July 2023

Major cannabis firms are streamlining their North American operations and reallocating resources toward markets with what they see as more long-term growth potential ...

Aussie approval puts Chanelle McCoy on the way toward OTC sleeping aid sales

Written by Tiziana Cauli | 19th January 2023

CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies ...

Hong Kong to ban CBD in the new year, ending a once-burgeoning business

Written by CannIntelligence | 19th December 2022

The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin...

With a new bill and a quiet opposition, is Australia closer to legalising cannabis?

Written by CannIntelligence | 11th November 2022

In a first attempt to legalise cannabis through the federal parliament in Australia, the Greens party is in the process of drafting a law for legalisation that will be available for public consultation later this year...

Aurora enjoys a profitable new dawn in international medical cannabis markets

Written by Antonia Di Lorenzo | 12th October 2022

Canadian company Aurora Cannabis has seen continued growth in its international business thanks to an increasing presence in emerging medical cannabis markets, notably Germany, the UK, Australia and Poland ...

Exit Tikun, another victim of Australia's tight regulation and low medical sales

Written by Lorraine Mullaney | 4th August 2022

One of the first companies involved in medical cannabis is the latest bankruptcy casualty in the volatile global cannabis market – citing slower than expected sales due to more rigorous than expected regulations ...

CBD and cannabis on Australia’s horizon – but don’t thank Labor government

Written by Tiziana Cauli | 25th July 2022

CBD products may start to appear on the Australian market but it will not be due to any action taken by the newly elected Labor government, according to industry insiders and experts ...

International acquisitions chase share of growing global medicinal market

Written by Lorraine Mullaney | 11th July 2022

The growth potential of demand for medicinal cannabis is inspiring cross-border acquisitions of pharmaceutical brands as businesses scale up to take a bigger slice of the global market ...

Lausanne aims to become home to Switzerland’s second cannabis trial

Written by CannIntelligence | 8th June 2022

Lausanne could become the second Swiss city after Basel to launch a recreational cannabis trial this year. But while Basel’s pilot will involve just 400 participants, Lausanne is aiming for triple that number ...

Australian companies looking to sell CBD treatments online with prescriptions

Written by Tiziana Cauli | 8th June 2022

Companies are trying new ways to reach cannabinoid customers in severely restricted Australia, but they must be careful not to fall foul of strict guidelines that separate promoting from simply informing the public about prescription...

New studies explore how cannabis can help improve women’s menstrual health

Written by Lorraine Mullaney | 12th May 2022

Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis ...

More medical applications for cannabinoids being explored

Written by Lorraine Mullaney | 4th March 2022

Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting...

US DEA calls for big increases in cannabis and psilocybin production for research

Written by Lorraine Mullaney | 23rd September 2021

The US Drug Enforcement Agency (DEA) is calling for an increase in production of cannabis and psychedelics to supply federal research and clinical trials ...

The entourage effect: new studies could help to explain the phenomenon

Written by CannIntelligence | 18th August 2021

Two new studies on the biochemistry of cannabinoids could provide answers to a puzzling question – how does the entourage effect work? ...

Cann Group teams up with Emyria to develop pharmacy grade CBD capsules

Written by Lorraine Mullaney | 21st April 2021

Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria ...

Tilray expands its influence Down Under, moving on New Zealand medical market

Written by Lorraine Mullaney | 15th April 2021

Canadian cannabis firm Tilray is moving in on New Zealand’s market for medical cannabis and has received the necessary approvals to launch Tilray medical cannabis products across the country ...

How cannabis derivatives could help to preserve the miracle of modern medicine

Written by CannIntelligence | 13th April 2021

Could cannabinoids, including CBD, provide a partial solution to the growing danger of diseases becoming resistant to existing antibiotics? ...

US and Australian cannabis companies see great profit potential in Europe

Written by Lorraine Mullaney | 2nd April 2021

There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company ...

CBD health and wellness subcategory sees advances on a global scale

Written by Lorraine Mullaney | 5th February 2021

CBD firms are making further advances into the health and wellness subcategory of the market with new product launches, distribution deals, and clinical studies underway ...

The entourage effect – absence of evidence, but no evidence of absence

Written by CannIntelligence | 11th August 2020

Some recent research has cast doubt on the idea that cannabis compounds may be more effective when taken together ...

Australia consults on re-scheduling CBD to be sold on pharmacist’s advice

Written by Freddie Dawson | 28th April 2020

Australia has unveiled a consultation on a proposal to classify CBD products as over-the-counter medications, available in pharmacies after consultation with a pharmacist ...

Epidiolex passes another clinical trial for treatment of Dravet syndrome

Written by Freddie Dawson | 11th March 2020

Results from a successful phase three clinical trial on the use of Epidiolex to treat drug-resistant Dravet syndrome have been published in the JAMA Neurology journal ...

Would you like a dash of CBD with your burger? Business news in brief

Written by CannIntelligence | 5th March 2020

A Denver-based chain claims to be the first CBD burger franchise in the US, while a Japanese company says it can extract CBD from orange peel. These and other stories are in CBD-Intel's latest round-up...

Toothpaste giant enters CBD market: business news in brief

Written by CannIntelligence | 26th February 2020

Toothpaste giant Colgate is entering the CBD market, researchers have created a laser scanner that can tell the difference between legal hemp and potentially illegal cannabis, and wrestling legend Kevin Nash has become the latest...

Actor refutes claims he endorsed CBD products: business news in brief

Written by CannIntelligence | 18th February 2020

Tom Hanks refutes false claims over endorsement of CBD products, research suggests cannabinoids benefit gene receptor diseases and CBD coffee is set to hit the market, plus more ...

Guitar legend to launch his own CBD range: business news in brief

Written by CannIntelligence | 30th January 2020

Guitar legend Carlos Santana is teaming up with a legal cannabis company to have his own branded range of CBD; a CBD firm plans to replant burnt Australian trees, and a French restaurant offers a...

Rugby league stars to promote CBD brand on kit: business news in brief

Written by CannIntelligence | 21st January 2020

CBD-Intel brings you news that a rugby league team will be the first senior outfit in its sport to promote a CBD brand on its kit, a qualification for hemp production is offered in Kentucky...

CBD 'most searched health term in the US': CBD business news in brief

Written by CannIntelligence | 4th November 2019

According to research from San Diego State University, CBD is the most searched health term in the US. Also covered are further stories from the US, Australia, India, Italy and Switzerland ...

CBD-Intel business news in brief

Written by CannIntelligence | 23rd October 2019

A legal battle between a Canadian cannabis company and a US hemp company leads this round-up of business news in brief. Also covered are stories from Australia, Germany, and a number of US states ...

CBD-Intel business news in brief

Written by CannIntelligence | 26th September 2019

A San Francisco-based CBD firm is donating all September profits from its bestselling line to Leonardo DiCaprio’s Earth Alliance Amazon Forest Fund. This and other business news in brief ...

CBD regulatory news in brief, 3rd - 9th September

Written by CannIntelligence | 9th September 2019

South Dakota governor Kristi Noem has explained why she continues to oppose hemp legalisation in the state; Flanders in Belgium is seeing enforcement action against CBD shops because of CBD oils and teas; Australian state...

CBD-Intel business news in brief, 10th-16th August 2019

Written by CannIntelligence | 19th August 2019

Kylie Jenner gets happy – CBD-Intel’s weekly round-up of business snippets includes items from the US, Canada, Ireland and Australia ...

New clinical trial investigates CBD-infused oral health products

Written by Lorraine Mullaney | 19th August 2019

A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease. The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and...

CBD-Intel business news in brief, 29th July-2nd August 2019

Written by CannIntelligence | 5th August 2019

US food and pharmacy chain Kroger has increased its range of CBD products with deals to distribute CV Sciences, Veritas Farms and Charlotte’s Web products in 1350 stores across 22 states ...

CBD-Intel business news in brief, 15th-19th July 2019

Written by CannIntelligence | 22nd July 2019

Christian Books or hemp extract? CBD-Intel brings you a pot-pourri of CBD-related news snippets from around the business world ...

CBD-Intel business news in brief, 1st-5th July 2019

Written by CannIntelligence | 8th July 2019

Elvis Presley CBD for your hound dog? CBD-Intel’s business news round-up includes items from New York, British Columbia, Ireland, the UK, Hong Kong, Israel, Australia and Colombia ...

CBD regulatory news in brief,
10th-16th June 2019

Written by CannIntelligence | 17th June 2019

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel ...

Australia gearing up for an export boom in organic hemp and CBD

Written by ECigIntelligence | 1st November 2018

Australia may become a big exporter of organic hemp products, especially to Asia, according to the president of the Australian Industrial Hemp Alliance (AIHA) ...

LATEST ALERTS